Contact Us

Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

January

15
2025

Sensus Healthcare Reports First Quarter 2025 Financial Results

21 SRT systems shipped during the quarter; revenues of $8.3…

Read More

January

12
2019

Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare’s SRT-100™ for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities

Data from this Non-Invasive, Highly Effective Treatment Option for Non-Melanoma…

Read More

January

12
2019

Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare’s SRT-100™ for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities

Data from this Non-Invasive, Highly Effective Treatment Option for Non-Melanoma…

Read More

January

30
2019

Sensus Healthcare to Host Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference Call on February 14, 2019

BOCA RATON, Fla., Jan. 30, 2019 — Sensus Healthcare, Inc….

Read More

January

30
2019

Sensus Healthcare to Host Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference Call on February 14, 2019

BOCA RATON, Fla., Jan. 30, 2019 — Sensus Healthcare, Inc….

Read More
Categories
Categories
Archives
Archives
SRT-100 LOCATOR
Physician Login